{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T03:17:57Z","timestamp":1772507877329,"version":"3.50.1"},"reference-count":61,"publisher":"Impact Journals, LLC","issue":"101","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,12,25]]},"DOI":"10.18632\/oncotarget.26499","type":"journal-article","created":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T17:25:06Z","timestamp":1545758706000},"page":"37549-37563","source":"Crossref","is-referenced-by-count":6,"title":["PARP inhibition prevents escape from a telomere-driven crisis and inhibits cell immortalisation"],"prefix":"10.18632","volume":"9","author":[{"given":"Greg","family":"Ngo","sequence":"first","affiliation":[{"name":"Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Hyatt","sequence":"additional","affiliation":[{"name":"Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Grimstead","sequence":"additional","affiliation":[{"name":"Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhiannon","family":"Jones","sequence":"additional","affiliation":[{"name":"Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Hendrickson","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Pepper","sequence":"additional","affiliation":[{"name":"University of Sussex, Brighton and Sussex Medical School, Brighton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan","family":"Baird","sequence":"additional","affiliation":[{"name":"Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,12,25]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2016.171","article-title":"Telomeres in cancer: tumour suppression and genome instability","volume":"18","author":"de Lange","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nrm.2016.43","article-title":"Stop pulling my strings - what telomeres taught us about the DNA damage response","volume":"17","author":"Sfeir","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0959-8049(97)00065-8","article-title":"Telomere dynamics and telomerase activityimmortalised human cells","volume":"33","author":"Reddel","year":"1997","journal-title":"Eur J Cancer"},{"key":"4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature02118","article-title":"A DNA damage checkpoint response in telomere-initiated senescence","volume":"426","author":"Jackson","year":"2003","journal-title":"Nature"},{"key":"5","first-page":"1885","article-title":"Escape from senescence in human diploid fibroblasts induced directly by mutant p53","volume":"9","author":"Wynford-Thomas","year":"1994","journal-title":"Oncogene"},{"key":"6","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/j.1460-2075.1992.tb05245.x","article-title":"Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity","volume":"11","author":"Bacchetti","year":"1992","journal-title":"EMBO J"},{"key":"7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/35020592","article-title":"Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice","volume":"406","author":"DePinho","year":"2000","journal-title":"Nature"},{"key":"8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0092-8674(00)80762-X","article-title":"p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis","volume":"97","author":"DePinho","year":"1999","journal-title":"Cell"},{"key":"9","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1182\/blood-2010-02-272104","article-title":"Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis","volume":"116","author":"Baird","year":"2010","journal-title":"Blood"},{"key":"10","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1093\/jnci\/djt191","article-title":"Extensive telomere erosion in the initiation of colorectal adenomas and its association with chromosomal instability","volume":"105","author":"Baird","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/bjh.14666","article-title":"Telomere length is an independent prognostic marker in MDS but not inAML","volume":"178","author":"Fegan","year":"2017","journal-title":"Br J Haematol"},{"key":"12","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1158\/1078-0432.CCR-0984-03","article-title":"Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis","volume":"10","author":"De Marzo","year":"2004","journal-title":"Clin Cancer Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/modpathol.3800591","article-title":"Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma","volume":"19","author":"Argani","year":"2006","journal-title":"Mod Pathol"},{"key":"14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/bjh.13023","article-title":"Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease","volume":"167","author":"Fegan","year":"2014","journal-title":"Br J Haematol"},{"key":"15","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.molonc.2015.02.003","article-title":"Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients","volume":"9","author":"Baird","year":"2015","journal-title":"Mol Oncol"},{"key":"16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/bjh.14643","article-title":"Telomere length is a critical determinant for survival in multiple myeloma","volume":"178","author":"Baird","year":"2017","journal-title":"Br J Haematol"},{"key":"17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","article-title":"A survey of telomerase activity in human cancer","volume":"33","author":"Bacchetti","year":"1997","journal-title":"Eur J Cancer"},{"key":"18","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.celrep.2014.07.007","article-title":"Escape from Telomere-Driven Crisis Is DNA Ligase III Dependent","volume":"8","author":"Baird","year":"2014","journal-title":"Cell Rep"},{"key":"19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nrm.2017.48","article-title":"Non-homologous DNA end joining and alternative pathways to double-strand break repair","volume":"18","author":"Lieber","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"20","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1093\/nar\/gkl840","article-title":"PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways","volume":"34","author":"Iliakis","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1093\/nar\/gkq387","article-title":"The alternative end-joining pathway for repair of DNA double-strand breaks requires PARP1 but is not dependent upon microhomologies","volume":"38","author":"Dahm-Daphi","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.molcel.2015.01.034","article-title":"Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance","volume":"58","author":"Bai","year":"2015","journal-title":"Mol Cell"},{"key":"23","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: Synthetic lethality in the clinic","volume":"355","author":"Ashworth","year":"2017","journal-title":"Science"},{"key":"24","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","author":"Helleday","year":"2005","journal-title":"Nature"},{"key":"25","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Smith","year":"2005","journal-title":"Nature"},{"key":"26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrc.2015.21","article-title":"BRCAness revisited","volume":"16","author":"Ashworth","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1158\/1535-7163.MCT-13-0683","article-title":"The use of Olaparib (AZD2281) potentiates SN-38 cytotoxicity in colon cancer cells by indirect inhibition of Rad51-mediated repair of DNA double-strand breaks","volume":"13","author":"Sugano","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"28","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1038\/bjc.2014.91","article-title":"Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules","volume":"110","author":"Curtin","year":"2014","journal-title":"Br J Cancer"},{"key":"29","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1182\/blood-2014-01-548800","article-title":"PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH\/ROS balance","volume":"124","author":"Pellat-Deceunynck","year":"2014","journal-title":"Blood"},{"key":"30","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1101\/gad.439107","article-title":"The nature of telomere fusion and a definition of the critical telomere length in human cells","volume":"21","author":"Baird","year":"2007","journal-title":"Genes Dev"},{"key":"31","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.ccr.2012.03.044","article-title":"Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells","volume":"21","author":"de Lange","year":"2012","journal-title":"Cancer Cell"},{"key":"32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.molcel.2013.06.006","article-title":"The telomere deprotection response is functionally distinct from the genomic DNA damage response","volume":"51","author":"Karlseder","year":"2013","journal-title":"Mol Cell"},{"key":"33","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1158\/1535-7163.MCT-13-0803","article-title":"Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib","volume":"13","author":"Pommier","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"34","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1093\/nar\/gkq1241","article-title":"Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate","volume":"39","author":"Helleday","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"35","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-12-2753","article-title":"Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors","volume":"72","author":"Pommier","year":"2012","journal-title":"Cancer Res"},{"key":"36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nbt.2121","article-title":"Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors","volume":"30","author":"Pellicciari","year":"2012","journal-title":"Nat Biotechnol"},{"key":"37","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1021\/acs.jmedchem.6b00990","article-title":"Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors","volume":"60","author":"Schuler","year":"2017","journal-title":"J Med Chem"},{"key":"38","doi-asserted-by":"publisher","first-page":"34821","DOI":"10.18632\/oncotarget.26201","article-title":"PARP1 is required for preserving telomeric integrity but is dispensable for A-NHEJ","volume":"9","author":"Hendrickson","year":"2018","journal-title":"Oncotarget"},{"key":"39","doi-asserted-by":"publisher","first-page":"362ps17","DOI":"10.1126\/scitranslmed.aaf9246","article-title":"Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action","volume":"8","author":"de Bono","year":"2016","journal-title":"Sci Transl Med"},{"key":"40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bcp.2012.03.018","article-title":"The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art","volume":"84","author":"Dantzer","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"41","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1101\/gad.251611.114","article-title":"TRF1 negotiates TTAGGG repeat-associated replication problems by recruiting the BLM helicase and the TPP1\/POT1 repressor of ATR signaling","volume":"28","author":"de Lange","year":"2014","journal-title":"Genes Dev"},{"key":"42","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1128\/MCB.21.13.4129-4139.2001","article-title":"ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1","volume":"21","author":"Piwnica-Worms","year":"2001","journal-title":"Mol Cell Biol"},{"key":"43","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/12680","article-title":"Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability","volume":"23","author":"Jackson","year":"1999","journal-title":"Nat Genet"},{"key":"44","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.1093\/nar\/gkn615","article-title":"Rapid regulation of telomere length is mediated by poly(ADP-ribose) polymerase-1","volume":"36","author":"Burkle","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"45","doi-asserted-by":"publisher","first-page":"83754","DOI":"10.18632\/oncotarget.19410","article-title":"Inhibitors of telomerase and poly(ADP-ribose) polymerases synergize to limit the lifespan of pancreatic cancer cells","volume":"8","author":"Ouellette","year":"2017","journal-title":"Oncotarget"},{"key":"46","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1091\/mbc.e05-07-0672","article-title":"PARP1 Is a TRF2-associated poly(ADP-ribose)polymerase and protects eroded telomeres","volume":"17","author":"Liu","year":"2006","journal-title":"Mol Biol Cell"},{"key":"47","doi-asserted-by":"publisher","first-page":"6280","DOI":"10.1038\/onc.2010.344","article-title":"PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy","volume":"29","author":"Zupi","year":"2010","journal-title":"Oncogene"},{"key":"48","doi-asserted-by":"publisher","first-page":"10881","DOI":"10.1038\/ncomms10881","article-title":"TRF2-RAP1 is required to protect telomeres from engaging in homologous recombination-mediated deletions and fusions","volume":"7","author":"Chang","year":"2016","journal-title":"Nat Commun"},{"key":"49","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/nsmb.3451","article-title":"TRF2 binds branched DNA to safeguard telomere integrity","volume":"24","author":"de Lange","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"50","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1158\/0008-5472.CAN-15-3240","article-title":"The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models","volume":"76","author":"Rottenberg","year":"2016","journal-title":"Cancer Res"},{"key":"51","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1073\/pnas.1016574108","article-title":"Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression","volume":"108","author":"Dantzer","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.yexcr.2014.07.003","article-title":"Poly(ADP-ribose) polymerases in double-strand break repair: focus on PARP1, PARP2 and PARP3","volume":"329","author":"Dantzer","year":"2014","journal-title":"Exp Cell Res"},{"key":"53","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.chembiol.2016.08.012","article-title":"Small-Molecule Chemical Probe Rescues Cells from Mono-ADP-Ribosyltransferase ARTD10\/PARP10-Induced Apoptosis and Sensitizes Cancer Cells to DNA Damage","volume":"23","author":"Lehtio","year":"2016","journal-title":"Cell Chem Biol"},{"key":"54","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/cmdc.200800010","article-title":"On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives","volume":"3","author":"Moroni","year":"2008","journal-title":"ChemMedChem"},{"key":"55","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1021\/cb4002014","article-title":"PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3\/PARP3","volume":"8","author":"Schuler","year":"2013","journal-title":"ACS Chem Biol"},{"key":"56","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1021\/acs.jmedchem.7b00137","article-title":"Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell Lines","volume":"60","author":"Salzer","year":"2017","journal-title":"J Med Chem"},{"key":"57","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Weinberg","year":"2011","journal-title":"Cell"},{"key":"58","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1111\/jgs.14969","article-title":"The Clinical Potential of Senolytic Drugs","volume":"65","author":"Robbins","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"59","doi-asserted-by":"publisher","first-page":"e0174833","DOI":"10.1371\/journal.pone.0174833","article-title":"Extensive telomere erosion is consistent with localised clonal expansions in Barrett\u2019s metaplasia","volume":"12","author":"Baird","year":"2017","journal-title":"PLoS One"},{"key":"60","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ccell.2017.05.011","article-title":"ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma","volume":"32","author":"Bao","year":"2017","journal-title":"Cancer Cell"},{"key":"61","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1093\/nar\/gkr1117","article-title":"Mre11 modulates the fidelity of fusion between short telomeres in human cells","volume":"40","author":"Baird","year":"2012","journal-title":"Nucleic Acids Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T20:11:07Z","timestamp":1589055067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,25]]},"references-count":61,"journal-issue":{"issue":"101","published-print":{"date-parts":[[2018,12,25]]}},"alternative-id":["26499","30680069"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.26499","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,25]]}}}